世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

メディカルフーズの世界市場 2022-2026年


Global Medical Foods Market 2022-2026

医療用食品の世界市場 2022-2026年 Technavio社は、医療用食品市場をモニタリングしており、予測期間中に5.42%のCAGRで進行し、2022年から2026年にかけて58億8,000万ドルの成長が見込まれています。当レポートで... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2021年10月20日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

医療用食品の世界市場 2022-2026年
Technavio社は、医療用食品市場をモニタリングしており、予測期間中に5.42%のCAGRで進行し、2022年から2026年にかけて58億8,000万ドルの成長が見込まれています。当レポートでは、医療用食品市場について、全体的な分析、市場規模と予測、トレンド、成長要因、課題に加えて、約25社のベンダーを対象としたベンダー分析を行っています。
本レポートでは、現在の世界市場のシナリオ、最新のトレンドとドライバー、そして市場全体の環境に関する最新の分析を提供しています。市場を牽引するのは、慢性疾患の有病率の上昇と、メディカルフードを採用する高齢者の増加です。さらに、慢性疾患の有病率の増加が市場の成長を後押しすることも予想されます。
医療用食品市場の分析には、製品セグメントと地域別の状況が含まれています。
Technavioの医療用食品市場は以下のように区分されています。
製品別
- 粉末
- 錠剤
- その他
地域別の状況
- 北アメリカ
- ヨーロッパ
- アジア
- ROW
本調査では、医療従事者や患者の間で臨床栄養に関する意識が高まっていることが、今後数年間の医療用食品市場の成長を促す主な理由の一つであるとしています。
Technavio社は、複数の情報源から得たデータを主要なパラメータの分析によって調査、合成、要約することで、市場の詳細な情報を提供しています。当レポートでは、医療用食品市場について以下の項目を取り上げています。
- 医療用食品市場のサイジング
- 医療用食品市場の予測
- 医療用食品市場の産業分析
Technavioの堅牢なベンダー分析は、クライアントの市場での地位向上を支援することを目的としており、本レポートではこれに沿って、医療用食品市場の主要ベンダーであるAbbott Laboratories、Danone SA、Fresenius Kabi AG、Medtrition Inc.、Metagenics Inc.、Nestle SA、Primus Pharmaceuticals Inc.、Proliant Inc.、Reckitt Benckiser Group Plc、Targeted Medical Pharma Inc.などの詳細な分析を行っています。また、医療用食品市場の分析レポートには、市場成長に影響を与える今後のトレンドや課題に関する情報も含まれています。これは、企業が戦略を立て、来るべきすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からの情報を含む一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加えて、包括的な市場およびベンダーランドスケープが含まれています。このレポートの詳細については、- https://www.technavio.com/report/medical-foods-market-industry-analysis をご覧ください。
Technavio社は、複数の情報源から得たデータを調査、合成、要約し、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することで、市場の詳細なイメージを提示しています。また、業界の主要なインフルエンサーを特定することで、様々な市場の側面を提示しています。提示されたデータは包括的で信頼性が高く、一次および二次両方の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場成長を予測するために、完全な競合状況と、質的・量的調査を用いた綿密なベンダー選択方法と分析を提供しています。

ページTOPに戻る


目次

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Powder - Market size and forecast 2021-2026
o Pill - Market size and forecast 2021-2026
o Others - Market size and forecast 2021-2026
o Market opportunity by Product
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Danone SA
o Fresenius Kabi AG
o Medtrition Inc.
o Metagenics Inc.
o Nestle SA
o Primus Pharmaceuticals Inc.
o Proliant Inc.
o Reckitt Benckiser Group Plc
o Targeted Medical Pharma Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Product - Market share 2021-2026 (%)
• 22: Comparison by Product
• 23: Powder - Market size and forecast 2021-2026 ($ million)
• 24: Powder - Year-over-year growth 2021-2026 (%)
• 25: Pill - Market size and forecast 2021-2026 ($ million)
• 26: Pill - Year-over-year growth 2021-2026 (%)
• 27: Others - Market size and forecast 2021-2026 ($ million)
• 28: Others - Year-over-year growth 2021-2026 (%)
• 29: Market opportunity by Product
• 30: Customer landscape
• 31: Market share By Geographical Landscape 2021-2026 (%)
• 32: Geographic comparison
• 33: North America - Market size and forecast 2021-2026 ($ million)
• 34: North America - Year-over-year growth 2021-2026 (%)
• 35: Europe - Market size and forecast 2021-2026 ($ million)
• 36: Europe - Year-over-year growth 2021-2026 (%)
• 37: Asia - Market size and forecast 2021-2026 ($ million)
• 38: Asia - Year-over-year growth 2021-2026 (%)
• 39: ROW - Market size and forecast 2021-2026 ($ million)
• 40: ROW - Year-over-year growth 2021-2026 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Abbott Laboratories - Overview
• 50: Abbott Laboratories - Business segments
• 51: Abbott Laboratories - Key offerings
• 52: Abbott Laboratories - Key customers
• 53: Abbott Laboratories - Segment focus
• 54: Danone SA - Overview
• 55: Danone SA - Business segments
• 56: Danone SA - Key offerings
• 57: Danone SA - Key customers
• 58: Danone SA - Segment focus
• 59: Fresenius Kabi AG - Overview
• 60: Fresenius Kabi AG - Business segments
• 61: Fresenius Kabi AG - Key offerings
• 62: Fresenius Kabi AG - Key customers
• 63: Fresenius Kabi AG - Segment focus
• 64: Medtrition Inc. - Overview
• 65: Medtrition Inc. - Product and service
• 66: Medtrition Inc. - Key offerings
• 67: Medtrition Inc. - Key customers
• 68: Medtrition Inc. - Segment focus
• 69: Metagenics Inc. - Overview
• 70: Metagenics Inc. - Business segments
• 71: Metagenics Inc. - Key offerings
• 72: Metagenics Inc. - Key customers
• 73: Metagenics Inc. - Segment focus
• 74: Nestle SA - Overview
• 75: Nestle SA - Business segments
• 76: Nestle SA - Key offerings
• 77: Nestle SA - Key customers
• 78: Nestle SA - Segment focus
• 79: Primus Pharmaceuticals Inc. - Overview
• 80: Primus Pharmaceuticals Inc. - Product and service
• 81: Primus Pharmaceuticals Inc. - Key offerings
• 82: Primus Pharmaceuticals Inc. - Key customers
• 83: Primus Pharmaceuticals Inc. - Segment focus
• 84: Proliant Inc. - Overview
• 85: Proliant Inc. - Product and service
• 86: Proliant Inc. - Key offerings
• 87: Proliant Inc. - Key customers
• 88: Proliant Inc. - Segment focus
• 89: Reckitt Benckiser Group Plc - Overview
• 90: Reckitt Benckiser Group Plc - Business segments
• 91: Reckitt Benckiser Group Plc - Key offerings
• 92: Reckitt Benckiser Group Plc - Key customers
• 93: Reckitt Benckiser Group Plc - Segment focus
• 94: Targeted Medical Pharma Inc. - Overview
• 95: Targeted Medical Pharma Inc. - Product and service
• 96: Targeted Medical Pharma Inc. - Key offerings
• 97: Targeted Medical Pharma Inc. - Key customers
• 98: Targeted Medical Pharma Inc. - Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Medical Foods Market 2022-2026
Technavio has been monitoring the medical foods market and it is poised to grow by $ 5.88 bn during 2022-2026, progressing at a CAGR of 5.42% during the forecast period. Our report on the medical foods market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic conditions and the increasing geriatric population adopting medical foods. In addition, the growing prevalence of chronic conditions is anticipated to boost the growth of the market as well.
The medical foods market analysis includes the product segment and geographic landscape.
Technavio's medical foods market is segmented as below:
By Product
• powder
• pill
• others
By Geographical Landscape
• North America
• Europe
• Asia
• ROW
This study identifies the rising awareness regarding clinical nutrition amongst healthcare professionals and patientsas one of the prime reasons driving the medical foods market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on medical foods market covers the following areas:
• Medical foods market sizing
• Medical foods market forecast
• Medical foods market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading medical foods market vendors that include Abbott Laboratories, Danone SA, Fresenius Kabi AG, Medtrition Inc., Metagenics Inc., Nestle SA, Primus Pharmaceuticals Inc., Proliant Inc., Reckitt Benckiser Group Plc, and Targeted Medical Pharma Inc. Also, the medical foods market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/medical-foods-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Powder - Market size and forecast 2021-2026
o Pill - Market size and forecast 2021-2026
o Others - Market size and forecast 2021-2026
o Market opportunity by Product
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Danone SA
o Fresenius Kabi AG
o Medtrition Inc.
o Metagenics Inc.
o Nestle SA
o Primus Pharmaceuticals Inc.
o Proliant Inc.
o Reckitt Benckiser Group Plc
o Targeted Medical Pharma Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Product - Market share 2021-2026 (%)
• 22: Comparison by Product
• 23: Powder - Market size and forecast 2021-2026 ($ million)
• 24: Powder - Year-over-year growth 2021-2026 (%)
• 25: Pill - Market size and forecast 2021-2026 ($ million)
• 26: Pill - Year-over-year growth 2021-2026 (%)
• 27: Others - Market size and forecast 2021-2026 ($ million)
• 28: Others - Year-over-year growth 2021-2026 (%)
• 29: Market opportunity by Product
• 30: Customer landscape
• 31: Market share By Geographical Landscape 2021-2026 (%)
• 32: Geographic comparison
• 33: North America - Market size and forecast 2021-2026 ($ million)
• 34: North America - Year-over-year growth 2021-2026 (%)
• 35: Europe - Market size and forecast 2021-2026 ($ million)
• 36: Europe - Year-over-year growth 2021-2026 (%)
• 37: Asia - Market size and forecast 2021-2026 ($ million)
• 38: Asia - Year-over-year growth 2021-2026 (%)
• 39: ROW - Market size and forecast 2021-2026 ($ million)
• 40: ROW - Year-over-year growth 2021-2026 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Abbott Laboratories - Overview
• 50: Abbott Laboratories - Business segments
• 51: Abbott Laboratories - Key offerings
• 52: Abbott Laboratories - Key customers
• 53: Abbott Laboratories - Segment focus
• 54: Danone SA - Overview
• 55: Danone SA - Business segments
• 56: Danone SA - Key offerings
• 57: Danone SA - Key customers
• 58: Danone SA - Segment focus
• 59: Fresenius Kabi AG - Overview
• 60: Fresenius Kabi AG - Business segments
• 61: Fresenius Kabi AG - Key offerings
• 62: Fresenius Kabi AG - Key customers
• 63: Fresenius Kabi AG - Segment focus
• 64: Medtrition Inc. - Overview
• 65: Medtrition Inc. - Product and service
• 66: Medtrition Inc. - Key offerings
• 67: Medtrition Inc. - Key customers
• 68: Medtrition Inc. - Segment focus
• 69: Metagenics Inc. - Overview
• 70: Metagenics Inc. - Business segments
• 71: Metagenics Inc. - Key offerings
• 72: Metagenics Inc. - Key customers
• 73: Metagenics Inc. - Segment focus
• 74: Nestle SA - Overview
• 75: Nestle SA - Business segments
• 76: Nestle SA - Key offerings
• 77: Nestle SA - Key customers
• 78: Nestle SA - Segment focus
• 79: Primus Pharmaceuticals Inc. - Overview
• 80: Primus Pharmaceuticals Inc. - Product and service
• 81: Primus Pharmaceuticals Inc. - Key offerings
• 82: Primus Pharmaceuticals Inc. - Key customers
• 83: Primus Pharmaceuticals Inc. - Segment focus
• 84: Proliant Inc. - Overview
• 85: Proliant Inc. - Product and service
• 86: Proliant Inc. - Key offerings
• 87: Proliant Inc. - Key customers
• 88: Proliant Inc. - Segment focus
• 89: Reckitt Benckiser Group Plc - Overview
• 90: Reckitt Benckiser Group Plc - Business segments
• 91: Reckitt Benckiser Group Plc - Key offerings
• 92: Reckitt Benckiser Group Plc - Key customers
• 93: Reckitt Benckiser Group Plc - Segment focus
• 94: Targeted Medical Pharma Inc. - Overview
• 95: Targeted Medical Pharma Inc. - Product and service
• 96: Targeted Medical Pharma Inc. - Key offerings
• 97: Targeted Medical Pharma Inc. - Key customers
• 98: Targeted Medical Pharma Inc. - Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る